2/27
05:26 am
ktta
Pasithea Therapeutics Corp. (KTTA) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transcript [Seeking Alpha]
Low
Report
Pasithea Therapeutics Corp. (KTTA) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transcript [Seeking Alpha]
2/17
07:30 am
ktta
Pasithea Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference [Yahoo! Finance]
Low
Report
Pasithea Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference [Yahoo! Finance]
2/17
07:01 am
ktta
Pasithea Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Low
Report
Pasithea Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
1/18
01:00 am
ktta
Pasithea Therapeutics (NASDAQ:KTTA) was upgraded by analysts at
Wall Str
Low
Report
Pasithea Therapeutics (NASDAQ:KTTA) was upgraded by analysts at
Wall Str
1/13
07:01 am
ktta
Pasithea Therapeutics Provides Outlook on PAS-004 Clinical Programs and Data Release Timelines
Low
Report
Pasithea Therapeutics Provides Outlook on PAS-004 Clinical Programs and Data Release Timelines
1/10
01:07 am
ktta
Pasithea Therapeutics (NASDAQ:KTTA) was upgraded by analysts at
Wall Str
Low
Report
Pasithea Therapeutics (NASDAQ:KTTA) was upgraded by analysts at
Wall Str
12/11
06:28 am
ktta
Pasithea Therapeutics (NASDAQ:KTTA) was upgraded by analysts at Zacks Research to a "hold" rating.
Low
Report
Pasithea Therapeutics (NASDAQ:KTTA) was upgraded by analysts at Zacks Research to a "hold" rating.
12/10
04:10 am
ktta
Pasithea Therapeutics (NASDAQ:KTTA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Pasithea Therapeutics (NASDAQ:KTTA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
12/9
08:11 am
ktta
Pasithea Therapeutics (NASDAQ:KTTA) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
Medium
Report
Pasithea Therapeutics (NASDAQ:KTTA) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
12/8
07:22 am
ktta
Pasithea Therapeutics (NASDAQ:KTTA) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
Low
Report
Pasithea Therapeutics (NASDAQ:KTTA) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
12/2
07:00 am
ktta
Pasithea Therapeutics Announces Closing of $60 Million Public Offering of Common Stock
Medium
Report
Pasithea Therapeutics Announces Closing of $60 Million Public Offering of Common Stock